Skip to the main content.
Let's Connect

Resource Center



Summit for Clinical Ops Executives 2024

For the 15th year in a row, BBK Worldwide will be participating in the Summit for Clinical Ops Executives (SCOPE) in ...

Join us at the Summit for Clinical Ops Executives (SCOPE) in Orlando, February 11-14, 2024.

January 29, 2024

2024: A Look into Our Crystal Ball

From efforts to improve DEI to the expansion of tech-engagement platforms and enrollment ecosystems, 2023 was a dynamic ...

From efforts to improve DEI to the expansion of tech-engagement platforms and enrollment ecosystems, 2023 was a dynamic year for clinical trial patient recruitment and engagement. But what’s in store for 2024? We asked five of our industry experts to weigh in with their predictions.

January 16, 2024

Turning Clinical Trials into Success Stories

To illustrate the impact of BBK Worldwide's recruitment and engagement solutions, we've created a story based on a ...

How Full-service Support Transforms a Typical Patient Experience

December 21, 2023

New Case Studies Illustrate the Breadth and Depth of BBK’s Impact

Ever wonder what BBK’s clinical trial support looks like in action? Our newly available case studies show just that!

These resources offer bite-size overviews of some of our thorniest clinical trial recruitment and engagement challenges — revealing the agile and innovative responses that ensure strong results for sponsors.

November 28, 2023

Waldenstrom Macroglobulinemia — Oncology — Phase 2

Our client hired us to provide Concierge travel support to an expansion cohort with Waldenstrom Macroglobulinemia, a ...

Through our TCN Arrive travel service, we created a customized, comprehensive and scalable long-term study visit stay program — all in just two weeks for these Waldenstrom Macroglobulinemia patients.

November 15, 2023

Leber Hereditary Optic Neuropathy — Ophthalmology — Phase 3

BBK Worldwide was hired to make study participation possible, let alone easier, for a group of patients with an acute ...

Leber Hereditary Optic Neuropathy (LHON), TCN Card patient reimbursement, TCN Arrive patient travel

October 17, 2023

Three Solutions to Help You Reach Your Year-end Enrollment Goals Ahead of the Pack

With the end of the year fast approaching, there's still time to achieve those critical clinical trial milestones.

With the end of the year fast approaching, there's still time to achieve those critical clinical trial milestones. With proven solutions, BBK can help you accelerate enrollment, reduce site burden, and keep timelines on track. BIO Notifier physician network, TCN Arrive travel, and TCN Card reimbursement.

October 4, 2023

Tenosynovial Giant Cell Tumor — Oncology — Phase 3

A rare and difficult-to-treat disease with patients who had suffered from multiple misdiagnoses, failed surgeries, ...

Tenosynovial giant cell tumor (TGCT), also known as pigmented villonodular synovitis (PVNS)

September 25, 2023

Top Five "Back to Basics" Patient Recruitment & Engagement Solutions

As we head into Fall, we're sharing five core solutions that are guaranteed to drive success for any patient ...

Five core solutions that are guaranteed to drive success for any patient recruitment or engagement campaign.

September 7, 2023

‘No Fate but what we Make’: AI Offers Great Potential for Clinical Trial Recruiting and Engagement

Machine learning, deep learning and algorithms holds potential to reduce time and costs of studies Artificial ...

BBK's writer, Jon Bloom, talks machine learning, deep learning and algorithms holding potential to reduce time & costs of studies

August 16, 2023

Innovating Patient Recruitment: A Conversation with BBK Worldwide's Founders

As BBK celebrates forty years strong, Joan F. Bachenheimer and Bonnie A. Brescia sit down with The Conference Forum to ...

As BBK celebrates forty years strong, Joan F. Bachenheimer and Bonnie A. Brescia sit down with The Conference Forum to discuss the past, present and future of clinical trial patient recruitment and engagement.

August 10, 2023

Early-Stage Breast Cancer — Oncology — Phase 3

Responding quickly and proactively to a breast cancer diagnosis can often make the difference in the success of a ...

BBK’s bold campaign created discussion opportunities between physicians and patients who were interested, yet hesitant to broach clinical study participation. An empowering message to “Come Out Fighting” coached aggressive pursuit of all treatment options, including this study.  Reigniting a lagging clinical study by getting physicians and patients to talk, BBK ultimately enrolled all 420 patients in only 10 months. Our approach got results with two months to spare — bringing medicine 60 days closer to finding the cure.

August 8, 2023

BBK Worldwide Launches VISION

BBK Worldwide (BBK), a Publicis Health company and global leader in patient recruitment and engagement, today announced ...

Publicis Health, the health and wellness vertical of Publicis Groupe, today announced the acquisition of BBK Worldwide (BBK), a full-service R&D marketing firm and a global leader in clinical trial experience (CTE). BBK enables biotech and pharmaceutical customers to accelerate R&D programs, driving research forward through the unique integration of patient-centric services and proprietary technology, complementing Publicis Health's existing CTE capabilities.

August 1, 2023

Need a good summer read? We've got you covered!

Temperatures are soaring and the beach is calling. It’s time to kick back, relax and enjoy a good summer read. Here are ...

BBK Worldwide top summer reads featuring content from Bonnie A Brescia, Rob Laurens, Martin Lawlor and Dena Raffa.

July 19, 2023

Early-Stage Parkinson's Disease — Neurology — Phase 2

Partially at-risk media placement, which dictated specific performance indicators for payment, created a partnership ...

The sponsor was looking to investigate a neurology investigational drug for early Parkinson's disease patients — BBK supported recruitment efforts with branded study material development, outreach directing to the program-level study website and prescreener which was further supported by referral management. Media was placed at-risk.

July 10, 2023

Top 10 Clinical Trial Management Solution Providers Features BBK

BBK Worldwide is one of the Top 10 Clinical Trial Management Solution Providers of 2023 according to Medhealth Outlook. ...

BBK Worldwide is one of the Top 10 Clinical Trial Management Solution Providers of 2023 according to Medhealth Outlook. The publication has prepared a list of some of the most innovative Clinical Trial management solution providers. The companies included in the list are the ones with some of the most outstanding solutions that could redefine the way the industry works today.

May 12, 2023

Strategies for the Successful Enrollment of Diverse and Inclusive Patient Populations

Gaby Grekin, BBK's senior director of global strategy, discusses making diversity, equity and inclusion (DEI) a ...

In this feature presentation, Gaby Grekin, senior director of global strategy, BBK Worldwide, discusses making diversity, equity and inclusion (DEI) a priority at the beginning of a trial. She addresses barriers to recruiting racially, ethnically and socio-economically diverse populations, and she shares strategies for overcoming challenges to ensure trials reflect the populations that will ultimately benefit from them.

May 10, 2023

Diverse Representation in Clinical Research: Building Bridges with the African American Community

This month BBK Worldwide is launching a new webcast series focused on diversity, equity and inclusion (DEI) in clinical ...

Michael Turner, BBK strategist and patient advocate, sits down with healthcare and community leaders to discuss whether the industry is doing enough to improve diversity, equity and inclusion (DEI). The group discusses the many complicated factors that impact the relationship between the Black community and the healthcare community as well as strategies to bring about effective change in DEI.

May 3, 2023

Endpoints News: Clinical Trial Advertising

Bonnie A. Brescia joins other industry thought leaders to share opinions on today’s clinical trial advertising in this ...

Bonnie A. Brescia joins other industry thought leaders to share their opinions on today’s clinical trial advertising in this feature article from Endpoints News.

May 2, 2023

As the Cookie Crumbles: Preparing for Patient Recruitment without Third-Party Cookies

Organizations conducting clinical trials have long relied upon the data gathered by third-party cookies to identify ...

Even though Google’s current plan does not pro-actively block third-party cookies until 2024, now is the time to begin adapting your strategies for identifying potential clinical trials participants. BBK's Martin Lawlor discusses alternate data sources you can look to as you begin developing that strategy.

April 20, 2023

Powering Diverse and Inclusive Clinical Trials

The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving ...

In this Medhealth Outlook article, Dena Raffa discusses how data, technologies, and engagement platforms are critical ways clinical trial sponsors can accomplish the new diversity, equity and inclusion (DEI) regulatory requirements from the FDA.

April 5, 2023

Forum on Clinical Trials

Gaby Grekin, Senior Director for Global Strategy, will be among the featured speakers at the Forum on Clinical Trials ...

Join us at the Xpectives.Health Summit April 18-20th and attend our presentation on Planning for Diversity, Equity and Inclusion in Clinical Trial Patient Recruitment

April 4, 2023

A Recruitment Veteran Looks at the Evolving Role of Patient-Centricity in Patient Recruitment

Bonnie A. Brescia, BBK founder and chief development officer, shares her perspective in the Patients as Partners in ...

Bonnie A. Brescia, founder and chief development officer at BBK Worldwide, shares her perspective on how patient-centricity in recruitment and retention has evolved, and how companies can shake up their activities.

March 21, 2023

Patients as Partners USA

Erica Mercado, Senior Account Supervisor, will be among the featured speakers at the Patients as Partners USA ...

Erica Mercado, Senior Account Supervisor, will be among the featured speakers at the Patients as Partners USA conference to be held in Washington, DC. She will be presenting “Make DEI Part of the Plan! Strategies for the Successful Enrollment of Diverse and Inclusive Patient Populations”

March 8, 2023

Publicis Health Launches Insagic, a Groundbreaking Insights and Advisory Business

Publicis Health Launches Insagic, a Groundbreaking Insights and Advisory Business Insagic expertly unites data science ...

Press Release: Publicis Health today announced the launch of Insagic, a new insights and advisory business that combines data, design, and dialogues to deliver the activatable insights and transformational intelligence that healthcare marketers need to succeed and grow in today’s platform world.

March 2, 2023

DIA 2023 Global Annual Meeting

Connect with us at this year’s DIA Global Annual Meeting held in our hometown of Boston.

Connect with us at this year’s DIA Global Annual Meeting held in our hometown of Boston and attend our presentation on good recruitment practice under Regulation (EU) No 536/2014.

February 20, 2023

Sickle Cell Disease — Hematology — Phase 2

With the study underway, BBK Worldwide was hired to drive enrollment in an increasingly competitive marketplace — and ...

The sponsor was looking to investigate a hematology investigational drug for diverse patients with sickle cell disease (SCD) — BBK supported recruitment efforts by developing study branded materials, developing digital outreach that directed to a study website and prescreener as well as concierge call center referral management.

February 17, 2023

Black and African Americans' Connections to Parkinson's Disease — Neurology — Phase 2

After previous successful recruitment partnerships with BBK Worldwide, the Michael J. Fox Foundation looked to BBK to ...

The sponsor was looking to recruit black or African American Parkinson's disease (PD) patients for an observational study — BBK supported recruitment efforts with branded study material development and digital outreach directing to the program-level study website and prescreener. The messaging was strategized with the assistance of patient interviews done with a patient advisory board.

February 17, 2023

Perspectives on Diversity in Healthcare

An annual faux pas most companies make during Black history month is trying to emphasize their commitment to diversity ...

An annual faux pas most companies make during Black history month is trying to emphasize their commitment to diversity and African American culture / history despite falling short in these efforts the remainder of the year.

February 16, 2023

PM360: Making Clinical Trials Better for Everyone in 2023

In the January / February issue of PM360, David Fleishman joins other industry thought leaders to share their thoughts ...

In the January / February issue of PM360, David Fleishman joins other industry thought leaders to share their thoughts on how to make the clinical trial process more efficient, easier and accessible to a wider group of patients. 

February 15, 2023

BBK Worldwide Launches TCN Engage

BBK Worldwide Launches TCN® Engage, a Disruptive Tech-Service Ecosystem for an Inclusive and Positive Clinical Trial ...

Press Release: BBK Worldwide (BBK), the global leader in maximizing the clinical trial experience for patients and providers, today announced the launch of TCN® Engage, a breakthrough engagement ecosystem dedicated to providing a full array of visit support services from the time a patient responds to an advertisement for a clinical trial opportunity through to their completion of the study.

February 7, 2023

Time for Action: The Immediate Impact of Regulation (EU) No 536/2014 on Patient Recruitment

The EU Clinical Trials Regulation (CTR) replaces the Clinical Trials Directive 2001 / 20 / EC and looks to ensure a ...

The Clinical Trials Regulation (EU) No 536/2014 looks to ensure a unified set of rules for conducting clinical trials in the EU. Discover the immediate impact on patient recruitment as outlined by Rob Laurens, Chief Patient Officer at BBK Worldwide.

January 31, 2023

Why Diversity Is Key to Clinical Trial Success

According to the Centers for Disease Control and Prevention (CDC), among the top ten leading causes of death in the ...

BBK Strategist Michael Turner discusses why diversity is key to clinical trial success.

January 2, 2023

Clinical Cuisine™ Named One of the Most Innovative Products of 2022

BBK's Clinical Cuisine™ was just selected as one of the most innovative products of 2022 by PM360 — a leading industry ...

Press Release: BBK's Clinical Cuisine™ was just selected as one of the most innovative patient engagement products of 2022 by PM360, a leading industry publication for the pharmaceutical, biotech, medical device and diagnostics industries. A first-of-its-kind service, Clinical Cuisine helps support patients and caregivers during clinical trial participation by removing the burden of meal planning and preparation.

December 28, 2022

The Necessity of Diverse and Inclusive Clinical Trials — and How to Get There

Marginalized populations continue to be underrepresented in clinical trials — hurting both the relevance of scientific ...

In the Autumn issue of International Clinical Trials, Senior Director of Global Strategy Gaby Grekin discusses the importance of improving diversity and inclusion in clinical trials as shares strategies for clinical trial sponsors to leverage.

November 29, 2022

Progressive Multiple Sclerosis — Neurology and Rare Disease — Observational Multicenter Trial

At the completion of the Phase 1 study effort, the sponsor looked to BBK Worldwide to support the recruitment of 80 ...

The sponsor was looking to investigate a neurology investigational drug for patients with progressive multiple sclerosis (MS) — BBK provided recruitment support, initiating study branding and materials, developing digital outreach directing to a study website and prescreener.

October 19, 2022

PM360: Taking the Necessary Steps to Enhance the Patient Experience

In the September issue of PM360, Rob Laurens joins other industry thought leaders to share their opinions on what it ...

In the September issue of PM360, Rob Laurens joins other industry thought leaders discussing what it takes today for life sciences companies to practice a patient-first approach.

September 29, 2022

Enteric Hyperoxaluria — Urology — Phase 1A/B

The client was struggling to enroll a clinical trial evaluating an investigational therapy for enteric hyperoxaluria in ...

The sponsor was looking to investigate a urology investigational drug for enteric hyperoxaluria patients — BBK provided recruitment support, initiating study branding and materials, developing digital outreach directing to a study website and prescreener, further supported by our concierge call center for referral management.

September 13, 2022

BBK Worldwide Selected as a Finalist for the 2022 Pharmaceutical Executive APEX Awards

BBK is a finalist for the 2022 Pharmaceutical Executive APEX Awards — the only healthcare marketing awards judged ...

BBK's patient recruitment campaign for Parkinson's disease has been selected as a finalist for the Pharmaceutical Executive APEX Awards

September 7, 2022

Enteric Hyperoxaluria — Urology — Phase 3

The sponsor was seeking to re-energize lagging enrollment for a clinical study for enteric hyperoxaluria.

The sponsor was looking to investigate a urology investigational drug for enteric hyperoxaluria patients — BBK provided rescue recruitment support, initiating study branding and materials, developing digital outreach directing to a study website and prescreener, further supported by our concierge call center for referral management.

August 10, 2022

Amyotrophic Lateral Sclerosis — Rare Neurology and Gene Therapy — Pivotal Study

The VALOR study sought to enroll patients with amyotrophic lateral sclerosis (ALS) who had a mutation in the superoxide ...

The sponsor was looking to investigate a gene therapy investigational drug for rare disease amyotrophic lateral sclerosis (ALS) patients — BBK supported global recruitment and engagement efforts by developing multi-protocol program level study branding and materials, outreach that directed to a study website and prescreener as well as reimbursement and complex travel support.

July 13, 2022

The Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity

In our latest podcast, BBK's Justin Jones and Gaby Grekin discuss strategies and insights that clinical trial sponsors ...

BBK's Justin Jones and Gaby Grekin discuss strategies and insights that clinical trial sponsors can leverage to make their studies more diverse and inclusive. 

June 14, 2022

Multiple Myeloma — Oncology — Phase 3

To randomize nearly 900 patients for two global research studies investigating potential new therapies for multiple ...

The sponsor was looking to investigate a oncology investigational drug for multiple myeloma patients — BBK supported global rescue recruitment efforts with branded study material development, consultation around site identification, and a clinician web forum.

June 9, 2022

Early Parkinson's Disease — Neurology — Multiprotocol Program-Level Support

The TemPo studies website and the study recruitment campaign took a sympathetic tone with the understanding that ...

The sponsor was looking to investigate a neurology investigational drug for early Parkinson's disease (PD) patients on a multi-protocol program level — BBK supported recruitment efforts with branded study material development, outreach directing to the program-level study website and prescreener which was further supported by our concierge call center for referral management.

June 9, 2022

South Korean Patients with Esophageal Cancer — Oncology and Gene Therapy — Phase 3

BBK was engaged to support enrollment in South Korea for a study of a PD-1 immune checkpoint inhibitor in patients with ...

The sponsor was looking to investigate a gene therapy oncology investigational drug for esophageal cancer patients — BBK supported South Korean recruitment efforts with by developing health care provider (HCP) or direct-to-physician outreach using database and directing to a study website where they could prescreen patients.

May 17, 2022

Pediatric Boys with Duchenne Muscular Dystrophy — Rare and Gene Therapy — Phase 3B

This clinical study featured a novel investigational approach that appealed to physicians dedicated to advancing ...

The sponsor was looking to investigate a gene therapy investigational drug for boys living with Duchenne Muscular Dystrophy (DMD) — BBK supported global recruitment and engagement efforts by developing study branded materials and outreach directing to a study website and presscreener in addition to providing eBinders and appreciation items for pediatric participants.

April 13, 2022

Overactive Bladder — Urology — Phase 3

BBK Worldwide was hired to support patient recruitment and engagement for a large global study investigating two ...

The sponsor was looking to investigate an urology investigational drug for overactive bladder patients — BBK supported recruitment efforts with study branded materials and outreach directing to a study website and prescreener.

April 13, 2022

Words Matter: The Hybrid Lexicon

In a time of confusing terminology, one thing is clear: what the industry used to consider exceptional is now ...

In a time of confusing terminology, one thing is clear: what the industry used to consider exceptional is now considered essential. Hear more from BBKs Gaby Grekin.

March 31, 2022

Study Voices Survey: Patients Want Choice Offered through Hybrid Enrollment Solutions

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial ...

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.

March 8, 2022

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

A massive three-year, four-protocol pivotal study requiring over 6,700 global participants demanded the highest level ...

The sponsor was looking to investigate a mental health investigational drug for US patients experiencing Major Depressive Disorder — BBK supported recruitment efforts with study branded outreach like digital media and television directing to a study website and prescreener.

February 5, 2022

Publicis Health Acquires BBK Worldwide

Publicis Health, the health and wellness vertical of Publicis Groupe, today announced the acquisition of BBK Worldwide ...

Press Release: Publicis Health, the health and wellness vertical of Publicis Groupe, today announced the acquisition of BBK Worldwide (BBK), a full-service R&D marketing firm and a global leader in clinical trial experience (CTE). BBK enables biotech and pharmaceutical customers to accelerate R&D programs, driving research forward through the unique integration of patient-centric services and proprietary technology, complementing Publicis Health's existing CTE capabilities.

January 18, 2022

Publicis Health Adds Clinical Trial Muscle with Purchase of BBK Worldwide

The deal gives Publicis Health access to BBK’s TrialCentralNet patient recruitment management platform.

The deal gives Publicis Health access to BBK’s TrialCentralNet patient recruitment management platform.

January 18, 2022

Publicis Health Snaps up R&D Marketing Group Tracking Real-World Clinical Trials — and Patient Sentiment

Publicis Health snaps up R&D marketing group tracking real-world clinical trials — and patient sentiment.

Publicis Health snaps up R&D marketing group tracking real-world clinical trials – and patient sentiment

January 18, 2022

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

This study evaluated an investigational therapy for spinal muscular atrophy (SMA).

The sponsor was looking to investigate a rare disease investigational drug for global pediatric patients with Spinal Muscular Atrophy (SMA) — BBK developed supporting recruitment and engagement efforts with study branding, materials and outreach directing to a study website and presscreener in addition to reimbursement and complex travel support.

December 13, 2021

Mike Johnson Discusses TCN™ Arrive Milestone with Outsourcing-Pharma

Earlier this week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to ...

Last week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to discuss the TCN™ Arrive travel program and its recent milestone of 20,000 completed trips.

October 21, 2021

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

BBK Worldwide was engaged by a leading pharmaceutical company for more than six years to provide clinical study travel ...

The sponsor was looking to investigate a rare neurological and inherited disease investigational drug for global familial amyloid polyneuropathy (FAP or TTR) patients — BBK supported engagement efforts with reimbursement, travel and medication delivery support.

October 12, 2021

TCN™ Arrive Reaches Major Milestone

Launched in 2012, TCN™ Arrive has made clinical trial participation possible for thousands of patients worldwide. ...

Launched in 2012, TCN® Arrive has made clinical trial participation possible for thousands of patients worldwide. 

September 22, 2021

Decentralized Clinical Trials: The Patient Perspective

We know the industry is ready to embrace decentralized clinical trials. But what about patients? What do they think ...

We recently spoke with bladder cancer patient and advocate Phil Kelly to get the patient perspective on decentralized clinical trials.

September 14, 2021

One-on-One with BBK Worldwide Director of Tech Experience Dena Raffa

There's no question that digital technology is changing the way we engage with patients and altering expectations for ...

There's no question that digital technology is changing the way we engage with patients and altering expectations for the patient experience. As part of our Pharma15 Live! series, we sat down with BBK's Director of Tech Experience Dena Raffa to get her perspective.

July 27, 2021

Strategy Rocks!

Ever since legendary management consultant Peter Drucker famously declared that “culture eats strategy for breakfast,” ...

Hear from Gaby Grekin on the context of patient recruitment for clinical trials, strategy retains its centrality at BBK Worldwide, serving as a fundamental catalyst of our award-winning marketing and creative efforts.

July 19, 2021

Improving Diversity and Inclusion in Clinical Trials

With health equity at the forefront of the conversation today, many clinical trial sponsors are seeking ways to create ...

With health equity at the forefront of the conversation, many clinical trial sponsors seek ways to create a more diverse and inclusive research environment.

June 14, 2021

Three Decentralized Clinical Trial Solutions Trending Now

Ever wonder which products and services study sponsors are leveraging for enrollment and engagement success?

Topics: Patient Reimbursement, Decentralized Trials, Medication Delivery, In-home Nurse Visits, Mobile Wallet

March 31, 2021

What Patients Think about Hybrid and Decentralized Clinical Trials

Patient advocates take center stage in this Pharma15 Live! overtime segment and share their thoughts on hybrid and ...

Patient advocates take center stage in this Pharma15 Live! overtime segment with Bonnie A. Brescia and share their thoughts on hybrid and decentralized clinical trials.

March 29, 2021

Choice Closes the Gap between Clinical Trial Interest and Action

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep ...

Choice Closes the Gap Between Clinical Trial Interest and Action

February 15, 2021

Study-Life Balance: Re-envisioning the Patient Experience

A new clinical trial construct leverages patient-centric solutions in response to today’s empowered healthcare ...

In this issue of International Clinical Trials, Jessica Kim discusses a new clinical trial construct leverages patient-centric solutions in response to today’s empowered healthcare consumer, who has expectations for an enhanced healthcare experience

May 25, 2020

Study-Life Balance: Reenvisioning the Patient Experience

BBK Worldwide is marking the evolution of the patient experience with the introduction of a new construct called ...

BBK Worldwide is marking the evolution of the patient experience with the introduction of a new construct called study-life balance. It leverages patient-centric solutions to help patients more easily integrate clinical trial participation into their daily lives.

May 18, 2020

Creating a Patient-Centric Environment for Decentralized Clinical Trials

As decentralized clinical trials reshape the clinical research landscape, BBK Worldwide experts Rob Laurens and Anthony ...

Creating a Patient-Centric Environment for Decentralized Clinical Trials with Rob Laurens and Anthony Gaudio

February 13, 2020

Pharma15 Live! A Candid Conversation with a Clinical Trial Participant

As part of our Pharma15 Live! web series, we recently had the opportunity to sit down with three-time clinical trial ...

Patient advocate Richard Brescia takes center stage in this Pharma15 Liand shares his thoughts on decentralized clinical trials and support options available.

April 16, 2019

The Engagement Equation

Aaron Fleishman and Sarah Mandracchia introduce a new model for clinical trial enrollment success.

Aaron Fleishman and Sarah Mandracchia introduce a new model for clinical trial enrollment success.

May 30, 2018

No results found

Subscribe to stay connected

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.